During the past decade, CHU de NICE conducted 412 clinical trials. In the 10-year time frame, 412 clinical trials started and 20 clinical trials were completed, i.e. on average, 4.9% percent of trials that started reached the finish line to date. In the past 5 years, 225 clinical trials started and 15 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de NICE" #1 sponsor was "Centre Hospitalier Universitaire de Nice" with 251 trials, followed by "Nantes University Hospital" with 21 trials sponsored, "Centre Hospitalier Universitaire de Saint Etienne" with 12 trials sponsored, "University Hospital, Bordeaux" with 10 trials sponsored and "University Hospital, Montpellier" with 10 trials sponsored. Other sponsors include 244 different institutions and companies that sponsored additional 122 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de NICE" #1 collaborator was "Ministry of Health, France" with 15 trials as a collaborator, "Centre Hospitalier Universitaire de Nice" with 8 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 5 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 5 trials as a collaborator and "Centre Hospitalier Universitaire de Besancon" with 4 trials as a collaborator. Other collaborators include 287 different institutions and companies that were collaborators in the rest 246 trials.

According to Clinical.Site data, the most researched conditions in "CHU de NICE" are "Multiple Sclerosis" (16 trials), "Crohn's Disease" (9 trials), "Melanoma" (8 trials), "Sepsis" (8 trials) and "COVID" (7 trials). Many other conditions were trialed in "CHU de NICE" in a lesser frequency.

Most popular intervention types in "CHU de NICE" are "Other" (170 trials), "Drug" (157 trials), "Procedure" (85 trials), "Device" (47 trials) and "Behavioral" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "blood sample" (8 trials), "Blood sample" (5 trials), "ELX/TEZ/IVA" (4 trials) and "IVA" (4 trials). Other intervention names were less common.

The vast majority of trials in "CHU de NICE" are 512 trials for "All" genders, 26 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 181 active trials in "CHU de NICE". 27 are not yet recruiting, 120 are recruiting, 31 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 231 completed trials in CHU de NICE, undefined suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de NICE, 5 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 29 trials, and there were also 208 trials that are defined as “Not Applicable".

CHU de NICE has several departments that took part in Clinical trials: "Service de Dermatologie - Hôpital l'Archet" - 8 trials, "Hôpital Pasteur; Service de Neurologie" - 8 trials, "Hôpital Archet 1/Service d'Hématologie Clinique" - 5 trials, "Service d'Infectiologie, Hôpital de l'Archet, CHU de Nice" - 2 trials, "Digestive department - Archet hospital" - 6 trials, "CHU Nice - Hôpital de l'Archet 2; service Hepato gastro enterologie" - 2 trials, "CHU de Nice - Hôpital de l'Archet 1 - Centre de Référence pour les Maladies Neuromusculaires et la SLA" - 2 trials, "Department of neurosurgery" - 2 trials, "CHU de nice - Anesthésie Réanimation" - 2 trials, "Hôpital Pasteur 2 - Service d'Ophtalmologie" - 2 trials, "CHU de Nice Service de néphrologie" - 2 trials, "Hôpital Pasteur - Service de Psychiatrie" - 2 trials